CCMDD: Tenofovir & Lamivudine & Dolutegravir (TLD) - Patient Registration or Transition Standard Operating Procedure
Outlines the process for switching stable adult patients on ART from first line regimen TEE (Tenofovir +Emtricitabine + Efavirenz) to TLD (Tenofovir + Lamivudine + Dolutegravir) in the CCMDD programme and the process for registration of new patients into CCMDD with regards to TLD.
- Health Facility staff
- Authorised Prescribers
- CCMDD service provider staff